0.1700
-0.0050
(-2.86%)
At close: January 10 at 2:34:43 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-539,709.0000
-350,572.0000
-224,401.0000
-147,180.0000
-100,064.0000
Investing Cash Flow
-541,893.0000
-342,598.0000
-24,116.0000
-142,117.0000
-234,233.0000
Financing Cash Flow
924,962.0000
1,229,200.0000
301,432.0000
294,179.0000
422,776.0000
End Cash Position
204,150.0000
699,179.0000
163,149.0000
110,234.0000
105,352.0000
Capital Expenditure
-11,403.0000
-7,729.0000
-10,816.0000
-6,528.0000
-2,933.0000
Issuance of Capital Stock
74,293.0000
385,759.0000
298,045.0000
291,241.0000
420,067.0000
Free Cash Flow
-551,112.0000
-358,301.0000
-235,217.0000
-153,708.0000
-102,997.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IUL.F ImmuCell Corporation
4.9200
+0.82%
SPL.AX Starpharma Holdings Limited
0.1220
+10.91%
MGNX MacroGenics, Inc.
3.1800
-5.07%
COCP Cocrystal Pharma, Inc.
2.2100
-7.14%
REVB Revelation Biosciences, Inc.
0.5288
-8.83%
AGIO Agios Pharmaceuticals, Inc.
34.42
-4.12%
OCUL Ocular Therapeutix, Inc.
8.21
-7.44%
IONS Ionis Pharmaceuticals, Inc.
33.46
-1.88%
PALI Palisade Bio, Inc.
1.9100
-4.98%
CRBU Caribou Biosciences, Inc.
1.6400
-4.65%